Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
5.60
+0.10 (1.82%)
At close: Nov 18, 2025

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 2.10B NGN in the quarter ending September 30, 2025, with 46.06% growth. This brings the company's revenue in the last twelve months to 6.40B, up 68.75% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.

Revenue (ttm)
6.40B
Revenue Growth
+68.75%
P/S Ratio
3.74
Revenue / Employee
36.57M
Employees
196
Market Cap
23.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.49B2.28B102.98%
Dec 31, 20232.21B-709.73M-24.31%
Dec 31, 20222.92B216.47M8.01%
Sep 30, 20222.70B-343.81M-11.28%
Sep 30, 20213.05B207.54M7.31%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition